Cargando…

Inhibition of Factor XI: A New Era in the Treatment of Venous Thromboembolism in Cancer Patients?

Direct oral anticoagulants against activated factor X and thrombin were the last milestone in thrombosis treatment. Step by step, they replaced antivitamin K and heparins in most of their therapeutic indications. As effective as the previous anticoagulant, the decreased but persistent risk of bleedi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Poenou, Géraldine, Heestermans, Marco, Lafaie, Ludovic, Accassat, Sandrine, Moulin, Nathalie, Rodière, Alexandre, Petit, Bastien, Duvillard, Cécile, Mismetti, Patrick, Bertoletti, Laurent
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572808/ https://www.ncbi.nlm.nih.gov/pubmed/37833881 http://dx.doi.org/10.3390/ijms241914433

Ejemplares similares

Factor XI Inhibition for the Prevention of Venous Thromboembolism: An Update on Current Evidence and Future perspectives
por: Poenou, Geraldine, et al.
Publicado: (2022)

Pulmonary Embolism in the Cancer Associated Thrombosis Landscape
por: Poenou, Géraldine, et al.
Publicado: (2022)

Immunothrombosis and the Role of Platelets in Venous Thromboembolic Diseases
por: Heestermans, Marco, et al.
Publicado: (2022)

Anticoagulants: A Short History, Their Mechanism of Action, Pharmacology, and Indications
por: Heestermans, Marco, et al.
Publicado: (2022)

Cardiac Biomarkers in Patients with Acute Pulmonary Embolism
por: Janisset, Luc, et al.
Publicado: (2022)

Assessment of bleeding risk in cancer patients treated with anticoagulants for venous thromboembolic events
por: Poénou, Géraldine, et al.
Publicado: (2023)

Editorial: Venous thromboembolism and pregnancy
por: Tardy, Bernard, et al.
Publicado: (2022)

Diagnostic Approach for Venous Thromboembolism in Cancer Patients
por: Helfer, Hélène, et al.
Publicado: (2023)

Maladies thromboemboliques veineuses chez les patients COVID-19 pris en charge au CHU de Saint-Étienne
por: Giraud, Marie, et al.
Publicado: (2021)

ThromboprophylaXIs with Factor XI/XIa inhibitors for venous thromboembolism
por: Porres-Aguilar, Mateo
Publicado: (2023)

Factor XI, a potential target for anticoagulation therapy for venous thromboembolism
por: Li, Tingting, et al.
Publicado: (2022)

Evaluation of the predictive value of the bleeding prediction score VTE‐BLEED for recurrent venous thromboembolism
por: Klok, Frederikus A., et al.
Publicado: (2019)

Venous thromboembolism and COVID-19
por: Bertoletti, L., et al.
Publicado: (2020)

Adult breast, lung, pancreatic, upper and lower gastrointestinal cancer patients with hospitalized venous thromboembolism in the national French hospital discharge database
por: Couturaud, F., et al.
Publicado: (2023)

The Association between Factor XI Deficiency and the Risk of Bleeding, Cardiovascular, and Venous Thromboembolic Events
por: Sharman Moser, Sarah, et al.
Publicado: (2021)

Impact of Medical Specialties on Diagnostic and Therapeutic Management of Elderly Cancer Patients
por: Lafaie, Ludovic, et al.
Publicado: (2023)

Factor XI Inhibitors for Prevention and Treatment of Venous Thromboembolism: A Review on the Rationale and Update on Current Evidence
por: Nopp, Stephan, et al.
Publicado: (2022)

Extended anticoagulation for the secondary prevention of venous thromboembolic events: An updated network meta-analysis
por: Mai, Vicky, et al.
Publicado: (2019)

Venous thromboembolic events during warm autoimmune hemolytic anemia
por: Audia, Sylvain, et al.
Publicado: (2018)

Venous thromboembolism and radiation therapy: The final radiation‐induced thrombosis study analysis
por: Daguenet, Elisabeth, et al.
Publicado: (2022)

Long-Term Anticoagulant Therapy of Patients with Venous Thromboembolism. What Are the Practices?
por: Mahé, Isabelle, et al.
Publicado: (2015)

Effect of weight-adjusted intermediate-dose versus fixed-dose prophylactic anticoagulation with low-molecular-weight heparin on venous thromboembolism among noncritically and critically ill patients with COVID-19: the COVI-DOSE trial, a multicenter, randomised, open-label, phase 4 trial
por: Zuily, Stéphane, et al.
Publicado: (2023)

Effectiveness and Safety of Oral Anticoagulants in the Treatment of Acute Venous Thromboembolism: A Nationwide Comparative Cohort Study in France
por: Bertoletti, Laurent, et al.
Publicado: (2022)

Associations between coagulation factor XII, coagulation factor XI, and stability of venous thromboembolism: A case-control study
por: Meng, Yan, et al.
Publicado: (2022)

Management of Cancer-Associated Thrombosis in France: A National Survey among Vascular Disease and Supportive Care Specialists
por: Mahé, Isabelle, et al.
Publicado: (2022)

Recent advances in the treatment of venous thromboembolism in the era of the direct oral anticoagulants
por: Weitz, Jeffrey I., et al.
Publicado: (2017)

Venous Thromboembolism in Cancer: An Update of Treatment and Prevention in the Era of Newer Anticoagulants
por: Qureshi, Waqas, et al.
Publicado: (2016)

Obstructive Sleep Apnea, Hypercoagulability, and the Blood–Brain Barrier
por: Zolotoff, Cindy, et al.
Publicado: (2021)

Apixaban for treatment of venous thromboembolism in an obese patient with Glanzmann thrombasthenia
por: Sattler, Laurent, et al.
Publicado: (2023)

The management of acute venous thromboembolism in clinical practice: Results from the European PREFER in VTE Registry
por: Cohen, Alexander T., et al.
Publicado: (2017)

Prevention of venous thromboembolic events in patients with lower leg immobilization after trauma: Systematic review and network meta-analysis with meta-epsidemiological approach
por: Douillet, D., et al.
Publicado: (2022)

Venous thromboembolism /
por: Hirsh, Jack, 1935-
Publicado: (1981)

Thromboprophylaxis strategies to improve the prognosis of COVID-19
por: Bertoletti, Laurent, et al.
Publicado: (2021)

eThrombosis: A new risk factor for venous thromboembolism in the pandemic era
por: Sueta, Daisuke, et al.
Publicado: (2020)

The management of acute venous thromboembolism in clinical practice – study rationale and protocol of the European PREFER in VTE Registry
por: Agnelli, Giancarlo, et al.
Publicado: (2015)

Low Molecular Weight Heparin Treatment Patterns and Outcomes in Cancer Patients with Acute Venous Thromboembolism: A Nationwide Cohort Study in France
por: Bertoletti, Laurent, et al.
Publicado: (2023)

Aminotransferases disorders associated with venous thromboembolic events in patients infected with COVID-19
por: Hamadé, Amer, et al.
Publicado: (2021)

Pulmonary embolism response teams in the challenging era of venous thromboembolism associated with COVID-19
por: Porres-Aguilar, Mateo, et al.
Publicado: (2020)

Outside any therapeutic trial prescription of hydroxychloroquine for hospitalized patients with covid-19 during the first wave of the pandemic: A national inquiry of prescription patterns among French hospitalists
por: Bosquet, Antoine, et al.
Publicado: (2022)

Thalassemia and Venous Thromboembolism
por: Succar, Julien, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_4scsk0vmf83qjnc6int0q7js31